Patient Recruitment Strategies

Credence trials, a term that has gained traction in the realm of clinical research, refer to studies designed to evaluate the efficacy of treatments or interventions based on the subjective beliefs and perceptions of participants. Unlike traditional clinical trials that primarily focus on objective outcomes, credence trials delve into the psychological and emotional dimensions of […]

Noninferiority trials have emerged as a pivotal component in the landscape of clinical research, particularly in the evaluation of new treatments against established therapies. These trials are designed to demonstrate that a new intervention is not worse than an existing treatment by a pre-specified margin, known as the noninferiority margin. This approach is particularly valuable

The double-blinded randomized controlled trial (RCT) is a cornerstone of clinical research, particularly in the field of pharmacology. This methodological approach is designed to eliminate bias and ensure that the results of a study are as reliable and valid as possible. In a double-blinded RCT, neither the participants nor the researchers know who is receiving

A double-blinded randomized controlled trial (RCT) is a cornerstone of clinical research, designed to evaluate the efficacy and safety of new treatments or interventions. In this methodology, neither the participants nor the researchers know which individuals are receiving the treatment and which are receiving a placebo or an alternative intervention. This approach minimizes bias, ensuring

Double blind randomized controlled trials (RCTs) are considered the gold standard in clinical research, particularly in the evaluation of new pharmaceuticals and therapeutic interventions. This methodology is designed to eliminate bias, ensuring that neither the participants nor the researchers know who is receiving the treatment and who is receiving a placebo. This blinding process is

The Investigational Medicinal Product Dossier (IMPD) is a critical component in the realm of clinical trials, particularly those focused on developing new treatments for diseases such as cancer. The IMPD serves as a comprehensive document that outlines the quality, safety, and efficacy of an investigational medicinal product. It is a regulatory requirement in the European

Double blind trials are a cornerstone of clinical research, particularly in the field of pharmaceuticals. This methodology is designed to eliminate bias in the assessment of a new drug’s efficacy and safety. In a double blind trial, neither the participants nor the researchers know who is receiving the treatment and who is receiving a placebo.

Double blind trials are a cornerstone of clinical research, particularly in the field of medicine. These trials are designed to eliminate bias and ensure that the results are as objective as possible. In a double blind trial, neither the participants nor the researchers know who is receiving the treatment and who is receiving a placebo.

Clario CTMS, a comprehensive Clinical Trial Management System, has emerged as a pivotal tool in the realm of clinical research. Designed to facilitate the management of clinical trials, Clario CTMS integrates various functionalities that streamline processes, enhance data accuracy, and improve overall trial efficiency. As the demand for faster and more reliable clinical trials grows,

Entrust Clinical Research stands as a pivotal entity in the landscape of medical research, dedicated to the advancement of healthcare through rigorous clinical trials. Founded with the mission to bridge the gap between innovative medical ideas and their practical applications, Entrust has established itself as a leader in facilitating research that leads to significant health